Schedule I [21 CFR 1308.11]
Source: Shulgin, Alexander T. Controlled Substances: Chemical & Legal Guide to Federal Drugs Laws (2nd edition). Ronin Publishing Inc., Berkeley, 1992
Source: DEA Office of Diversion Control: Section 1308: Schedules of Controlled Substances
(e)
Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
Effective 13 Mar 2000, 65 FR 13235 added:
(1)
2010
Gamma-hydroxybutyric acid (GHB; Gamma-hydroxybutyrate; 4-Hydroxybutyrate; 4-Hydroxybutanoic acid; Sodium oxybate; Sodium oxybutyrate)
CA: CDSA Schedule I Section 21 4-Hydroxybutanoic acid
CA: [revoked] CDSA Schedule III Section 26 4-Hydroxybutanoic acid
UK: MDA Part III Class C Section 1(a) 4-Hydroxy-n-butyric acid
UN: Psychotropics Schedule II GHB
UN: [revoked] Psychotropics Schedule IV GHB
See also CSA Schedule III Section c Subsection 6 Gamma-hydroxybutyric acid
⇒
PubChem: 10413; ChemSpider: 9984; Drugs Forum: GHB; Erowid: GHB; Wikipedia: gamma-Hydroxybutyric acid
Effective 10 Jul 1975, 40 FR 28611a added:
On 29 May 1975, 40 FR 23306 proposed to add:
(2)
2572
Mecloqualone
CA: CDSA Schedule III Section 4 Mecloqualone
UK: MDA Part II Class B Section 1(a) Mecloqualone
UN: Psychotropics Schedule II Mecloqualone
Effective 27 Aug 1984, 49 FR 33870 added:
(3)
2565
Methaqualone
CA: CDSA Schedule III Section 3 Methaqualone
UK: MDA Part II Class B Section 1(a) Methaqualone
UN: Psychotropics Schedule II Methaqualone
⇒
PubChem: 6292; ChemSpider: 6055; Bluelight: Methaqualone; Drugs Forum: Methaqualone; Erowid: Methaqualone; Wikipedia: MethaqualoneEffective 20 Aug 1981, 46 FR 37503 added:
(f)
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
Effective 18 Mar 1994, 59 FR 12828 added (and renumbered subsequent entries):
(1)
1585
Aminorex (Aminoxaphen; 2-Amino-5-phenyl-2-oxazoline; 4,5-Dihydro-5-phenyl-2-oxazolamine)
Effective 6 Aug 2010, 75 FR 47503 corrected the claim made in 68 FR 52872 that BZP is 10 to 20 times more potent than amphetamine. Instead, the converse is now claimed: that BZP is 10 to 20 times less potent than amphetamine.
Effective 6 Aug 2010, 75 FR 47451 corrected the claim made in 68 FR 12794 that BZP is 10 to 20 times more potent than amphetamine. Instead, the converse is now claimed: that BZP is 10 to 20 times less potent than amphetamine.
Effective 18 Mar 2004, 69 FR 12794 added (and renumbered subsequent entries):
On 8 Sep 2003, 68 FR 52872 proposed to add (and to renumber subsequent entries):
(2)
7493
N-Benzylpiperazine (BZP; 1-Benzylpiperazine), its optical isomers, salts and salts of isomers
CA: CDSA Schedule III Section 33 Benzylpiperazine
EU: Substances Substances 1-Benzylpiperazine
UK: MDA Part III Class C Section 1(ca) 1-Benzylpiperazine
Effective 16 Feb 1993, 58 FR 4316 added:
(3)
1235
Cathinone (2-Amino-1-phenyl-1-propanone; Alpha-aminopropiophenone; 2-Aminopropiophenone; Norephedrone)
Effective 20 Aug 1981, 46 FR 37503 added:
(4)
1503
Fenethylline
CA: CDSA Schedule III Section 20 Fenetylline
UK: MDA Part III Class C Section 1(a) Fenethylline
UN: Psychotropics Schedule II Fenetylline
Effective 15 Oct 1993, 58 FR 53404 added (and renumbered subsequent entries):
(5)
1237
Methcathinone (2-(Methylamino)propiophenone; Alpha-(methylamino)propiophenone; 2-(Methylamino)-1-phenylpropan-1-one; Alpha-N-methylaminopropiophenone; Monomethylpropion; Ephedrone; N-Methylcathinone; Methylcathinone; AL-464; AL-422; AL-463; UR1432), its salts, optical isomers and salts of optical isomers
CA: CDSA Schedule III Section 21 2-Methylamino-1-phenyl-1-propanone
UK: MDA Part II Class B Section 1(a) Methcathinone
UN: Psychotropics Schedule I Methcathinone
⇒
PubChem: 1576; ChemSpider: 1519; Bluelight: methcathinone; Drugs Forum: methcathinone; Erowid: Cathinone and methcathinone; Wikipedia: Methcathinone
Effective 13 Apr 1989, 54 FR 14799 added (and renumbered subsequent entries):
(6)
1590
(±)-cis-4-Methylaminorex ((±)-cis-4,5-Dihydro-4-methyl-5-phenyl-2-oxazolamine)
CA: CDSA Schedule III Section 18 4-Methylaminorex
UK: MDA Part I Class A Section 1(a) 4-Methyl-aminorex
UN: Psychotropics Schedule I 4-Methylaminorex
⇒
PubChem: 92196; ChemSpider: 83237; Drugs Forum: 4-MAR; Erowid: 4-Methyl-aminorex; Wikipedia: 4-Methylaminorex
(7)
1475
N-Ethylamphetamine
CA: CDSA Schedule I Section 19 Subsection 2 N-Ethylamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 3 N-Ethylamphetamine
UK: MDA Part III Class C Section 1(a) N-Ethylamphetamine
UN: Psychotropics Schedule IV Etilamfetamine (N-Ethylamphetamine)
Effective 2 Feb 1990, 55 FR 3586 added (and renumbered subsequent entries):
(8)
1480
N,N-Dimethylamphetamine (N,N-Alpha-trimethyl-benzeneethanamine; N,N-Alpha-trimethylphenethylamine)
11 March 2016 · 
· Isomer Design
· Isomer Design